| Tag | Content |
|---|
EnhancerAtlas ID | HS197-11326 |
Organism | Homo sapiens |
Tissue/cell | ZR75-30 |
Coordinate | chr2:33754350-33756780 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Lhx3 | MA0135.1 | chr2:33755727-33755740 | AAATTAATTAATA | + | 6.37 | | POU6F1 | MA0628.1 | chr2:33755729-33755739 | ATTAATTAAT | + | 6.02 | | POU6F1 | MA0628.1 | chr2:33755729-33755739 | ATTAATTAAT | - | 6.02 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10669 | chr2:33752501-33759069 | CD19_Primary | | SE_10933 | chr2:33745911-33762201 | CD20 | | SE_59361 | chr2:33750852-33769157 | Ly3 | | SE_60768 | chr2:33750720-33761266 | DHL6 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 33755683 | 33756221 | | chr2 | 33756280 | 33756710 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I033529 | chr2 | 33754459 | 33758523 |
|
Enhancer Sequence | GGAGATCGAG ACCATCCTGG CTAACACGGT GAAACGCCAT CTCTACTAAA AATACAAAAA 60
AATTAGCTTG GCGTGGTGGC AGGTGCCTGT AGTCCCAGCT ATTTGGGAGG CTGAGGCAGA 120
AGAATGGCGT GAATCCGGGA GGTGGAGCTT GCAGCGAGCC GAGATGGTGC CACTGCACTG 180
GGCGACAGAG CGAGACTCCA TCTCAAAAAA AAAAAAATTC AGGAGTACAA ATGAAAAAAA 240
TCTGAACTCT AGAAATAAAG GCTAAGAAAA AAATTCCTTT TTGCTGGGGA GGAATCTTTC 300
TCTCTCTGTC TCATATTGAA GGAAAACTTA GAAGCCATCA AGCACTGTAT TTAGTAACTG 360
CAGTGTTGGG TAGCATAGTG TAGTGGCAAA ATCCTAGATG TGAGACCTTG CTTTCAGCCT 420
TCCCTCAGCA GTTGCTTGGT TTTGTCTCCT TGCTAACAGC CTTGACTTTG GCTTTTTTTA 480
AACAAGGGTT TTATGCTCAT TTGTGAGGTC TTTTCCAGCT CTAAACTTCT AGGATTCTAG 540
ATGTAAGAAC CAGTGGAGCC TTAAGAATAA GGAACCAAGA GTCAACTTGA TTCTGTAGTA 600
CCAGCCCAAT AGCTCATCAC GATAGCACAA TCCTGTGTAT GAGTCACCAA ACTTCCAGTC 660
AAGATCCTTT CTCTGTCCCC ACAGCCAAGA AGAAAGTTTA GTGCATAGCA GTATACATTC 720
CTTCTTCCTG ACTCCTGAGG ATTAATCTCC TCAACATGAG GACTGAGGAG GCTTCCATCT 780
TGTGGTCACT AGAGCCCAGC GGCCATTTTA GGAAGCACAC ACATATCTGG ATTAGACCCA 840
TATGGCTGAC CACAGCTGCC CCAATGCATG CGAAGGCATC CACATGCCAG CATTGGAAGG 900
GGTGATTCAT TTTGCCTCAG GACTCTAAAT TTTCTCCTGA AGTGATTGTT TTCATCTAAA 960
CATGGCTCCA GCTGAGGTCG CCTGTATATG ATGGACAGCC CTGGAGGACA GAAAAAGAGA 1020
ACCCTTATGT TCATCAACAA TTATGAAATG CCTACTCCGT GTGGTAGGCT GTAGGGCAGT 1080
GCTTTAACTT TCTGTAATAG TTAATTACAG TTTTCACAGC ACTTTTCACA TACGTTTCCT 1140
CAGTAAATTC TCACACATAC CCTGCAATGC AGCCTGGGCA GGGCTGTGAG TGTAACATCA 1200
CCCCTGCCCC TTCCTTTTTT TTTTTTTTTT TTTTTTTTAA ACTAAAGAAG AAACTGAGAT 1260
TTACAAAGGA CAGGGAGCAA ACTTCTGCAT CCCAGCCTGG GCCGGGTTCC CCTCAAATGG 1320
ACATTTGCTC TCTCATGTGG GCACACTGCT GACATCTCAT TTATTTCACA TCTGTAAAAA 1380
TTAATTAATA CTGCTCTCTC CTCCTCTTCA TGATGTGCAG TAAAGGAAGT AATTACAGGA 1440
CAAAATCTGT GAGGGTGGGG GCTATGTTTG TCATTTTTGT CATTGTATCC TTGGCCCCTT 1500
GAATACGGCA CCAGGCCTGT TGAGGGAAGG AGGACCACGC CACCAAACTG TTGGGATTTG 1560
TATTGTTCCT TCCTTTCAGG GAATATCTGG AGAGGACATT TGCCTTACAT CCCAATTCAC 1620
GTAACCAGGA GTTTTAAAAG CTGATGTTTC TGTTGCGTGG GGTATGAAAT AGTTTGAATC 1680
TTTTCATGGT ATTTTTAGCC CTATCAGTTA CTTTTACCAT TTTGAGTACA TGCAAATAAC 1740
TGGAAAGCCC CTGTATTTTT AATTTTAGTC TCATTTTTAA AAAAGAAGAA GAAGAATAAG 1800
AAGAGTTTCA AAAATGGTGA GTAGAGGCAG TCTGATGTCC AGGTGTGTTT TATTTTATGA 1860
TAAACAGTCA AGCCAATGTA GATCCTAATG AAGACTGAAT CTGCAACCAA CTTTGCTGAA 1920
AGGATAGGTT GGTAAATGCA ACAACTTGAA ACAGTGGATA AGAACATTTG TCAGAAAAAA 1980
ACAGCCAGGC TCAAAATATG TTTGACAAGA GCAAATGTTC TTGAAATTCC ATTGATGAGC 2040
AGCCCATATT ATAAAAACGT TGTGCAGAAA GTAGAACAGA TCACCCTTTG GGCAGGTCCG 2100
TAAAGCCCAG AGGAGATCTG AGAGAGGAAG TAGAATCGTG ACTGGGAAAG AAGAGATGCT 2160
AGGAGTAACC CCGAGGGCAG CTTTACATTC ACGGATAAGC ACAGTGGCAT TTGACTCGTG 2220
CATTGACTGG AAGCCAAACC CTGCATTTGT GACCTTCTAA ACAAACCTTA GTCAGACACC 2280
CATTAGCTCA TTTCATCTTC ACCATCGTTC TTGGAGGCAG CTATTATTTA TGATTCCCAT 2340
TTCACAGATC AGGAGACTGA GACTCAGGAA GGTTAACTGC ATGCCCAGGC TCACACTACT 2400
AATAAGCAGA GAGTGAGTAT TTGGAGACTA 2430
|
